Abstract
CCAAT/enhancer binding protein α (C/EBPα)-ER induces 32Dcl3 neutrophilic differentiation and inhibits 32DPKCδ maturation to macrophages in response to phorbol ester. In 32Dcl3 cells, C/EBPα-ER rapidly induces the PU.1 and C/EBPα RNAs even in the presence of cycloheximide, suggesting that these are direct C/EBPα genetic targets. C/EBPα strongly binds and modestly activates the murine PU.1 promoter via an evolutionarily conserved binding site. C/EBPα-ER variants incapable of binding DNA still slow G1 progression but do not induce differentiation. N-terminally truncated C/EBPα variants, including the p30 isoform expressed in a subset of AMLs, also retain the ability to slow 32D cl3 proliferation, whereas the C/EBPα(BRM2)-ER variant does not slow G1 progression, has a reduced capacity to induce early granulocytic markers, and does not induce terminal maturation. In 32DPKCδ cells, C/EBPα-ER strongly inhibits endogenous or exogenous JunB induction, dependent upon the outer surface of the C/EBPα basic region, but does not inhibit c-Jun, PU.1, or C/EBPβ expression. Exogenous JunB restores AP-1 DNA binding but does not overcome inhibition of monopoiesis by C/EBPα-ER. In summary, we propose that while C/EBPα is required for development of immature granulocyte–monocyte progenitors, C/EBPα subsequently inhibits monopoiesis, via inhibition of JunB express and via additional activities, and induces granulopoiesis, via induction of PU.1, C/EBPε, and cell cycle arrest.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.